Carly Kenselaar

Stock Analyst at Citigroup

(2.99)

# 1,169

Out of 4,804 analysts

6

Total ratings

80%

Success rate

45.14%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Carly Kenselaar

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	TVTX Travere Therapeutics	Maintains: Buy	$31 → $35	$14.35	+143.90%	5	Feb 24, 2025
	KRYS Krystal Biotech	Initiates: Buy	$160	$168.16	-4.85%	1	Oct 12, 2023

Travere Therapeutics

Feb 24, 2025

Maintains: Buy

Price Target: $31 → $35

Current: $14.35

Upside: +143.90%

Krystal Biotech

Oct 12, 2023

Initiates: Buy

Price Target: $160

Current: $168.16

Upside: -4.85%